Se-Yeong Oh

发表

Anticancer properties of extracts from Opuntia humifusa against human cervical carcinoma cells.

Kun-Young Park, Hyunggee Kim, S. Hahm, 2015, Journal of medicinal food.

RIOK2 drives glioblastoma cell proliferation by modulating MYC through the RNA-binding protein IMP3

Se-Yeong Oh, R. Read, Alexander S Chen, 2020, bioRxiv.

Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.

Yoon Young Choi, M. White, S. Paik, 2018, Gastroenterology.

Selective cell death of oncogenic Akt-transduced brain cancer cells by etoposide through reactive oxygen species–mediated damage

Hye-Min Jeon, Y. Sohn, Hyunggee Kim, 2007, Molecular Cancer Therapeutics.

Relationships of Circulating Concentrations of Insulin-like Growth Factor (IGF)-I and -II to Egg Production and Growth Rate in the Korean Native Ogol Chicken

Se-Yeong Oh, J. Yun, W. Kang, 2003 .

Brain cancer stem-like cell genesis from p53-deficient mouse astrocytes by oncogenic Ras.

Hye-Min Jeon, Y. Sohn, Hyunggee Kim, 2008, Biochemical and biophysical research communications.

Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.

L. Chin, R. DePinho, Hyunggee Kim, 2007, Cancer research.

Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.

D. Nam, Sung-Hak Kim, S. Beck, 2011, Biomaterials.

genesis through cyclin E and notch signaling Inhibitor of differentiation 4 drives brain tumor-initiating cell

L. Chin, R. DePinho, D. Nam, 2008 .

Interferon regulatory factor 3 activates p53-dependent cell growth inhibition.

Hyunggee Kim, Seungkwon You, Se-Yeong Oh, 2006, Cancer letters.

OVOL2 is a critical regulator of ER71/ETV2 in generating FLK1+, hematopoietic, and endothelial cells from embryonic stem cells.

M. Kyba, J. Kim, Se-Yeong Oh, 2014, Blood.

YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma

J. Olson, Se-Yeong Oh, R. Read, 2020, Clinical Cancer Research.

Survivin inhibits anti-growth effect of p53 activated by aurora B.

Ji-Eun Jung, Young-Woo Sohn, Young Ki Choi, 2005, Biochemical and biophysical research communications.

ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.

Hye-Min Jeon, Y. Sohn, Sung-Hak Kim, 2011, Cancer research.

Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling.

Young-Woo Sohn, Lynda Chin, Do-Hyun Nam, 2008, Genes & development.

The ETS Factor, ETV2: a Master Regulator for Vascular Endothelial Cell Development

J. Kim, Se-Yeong Oh, Changwon Park, 2015, Molecules and cells.

Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.

Hyunggee Kim, Se-Yeong Oh, Y. Lim, 2012, Experimental cell research.

Irradiation induces glioblastoma cell senescence and senescence-associated secretory phenotype

Hyunggee Kim, Jae-Bong Park, Jaebong Kim, 2016, Tumor Biology.

Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas.

Sung-Hak Kim, Hyunggee Kim, Se-Yeong Oh, 2011, Oral oncology.

The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.

Ji-Eun Jung, Young-Woo Sohn, Kai-Fu Tang, 2016, Cell reports.

Molecular Culprits Generating Brain Tumor Stem Cells

Hyunggee Kim, Se-Yeong Oh, 2013, Brain tumor research and treatment.

Direct Reprogramming of Human Dermal Fibroblasts Into Endothelial Cells Using ER71/ETV2

J. Kim, Y. Yoon, In-Hyun Park, 2017, Circulation research.

Conversion of glioma cells to glioma stem-like cells by angiocrine factors.

Hye-Min Jeon, Sung-Hak Kim, Hyunggee Kim, 2017, Biochemical and biophysical research communications.

Selective cytotoxicity of a novel mitochondrial complex I inhibitor, YK-135, against EMT-subtype gastric cancer cell lines due to impaired glycolytic capacity

G. Han, Se-Yeong Oh, Jooyoung Lee, 2022, BMB reports.

The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells

D. Nam, Hye-Min Jeon, Sung-Hak Kim, 2010, Molecules and cells.

Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.

I. Nakano, Hye-Min Jeon, Y. Sohn, 2014, Cancer letters.

CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.

Hyunggee Kim, Se-Yeong Oh, Y. Lim, 2013, European journal of cancer.

Erratum: The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells (Molecules and Cells 30 (2010) 403-408 (DOI:10.1007/s10059-010-0122-z)

D. Nam, Hye-Min Jeon, Hyunggee Kim, 2011 .

Erratum to: The Neural Stem Cell Fate Determinant TLX Promotes Tumorigenesis and Genesis of Cells Resembling Glioma Stem Cells

D. Nam, Hye-Min Jeon, Sung-Hak Kim, 2011 .

Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells.

D. Nam, Sung-Hak Kim, S. Beck, 2011, Biomaterials.

Anticancer properties of extracts from Opuntia humifusa against human cervical carcinoma cells.

Kun-Young Park, Hyunggee Kim, S. Hahm, 2015, Journal of medicinal food.